查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球免疫組織化學市場：按產品、按應用、按最終用戶、按地區、機會、預測，2017-2031 年
市場調查報告書
商品編碼
1422071

全球免疫組織化學市場：按產品、按應用、按最終用戶、按地區、機會、預測，2017-2031 年

Immunohistochemistry Market Assessment, By Product, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 220 Pages | 商品交期: 3-5個工作天內

價格

2023年全球免疫組化市場規模為30.1億美元，預估2031年將達49.9億美元，複合年增長率預估為6.51%。全球免疫組織化學市場的成長是由癌症發病率上升、技術進步、研究活動擴大、個人化醫療需求激增、醫療保健支出增加以及對精密診斷設備的需求所推動的。

全球免疫組織化學市場的成長取決於許多推動其上升勢頭的關鍵因素。主要催化劑將是全球癌症患者數量的迅速增加。免疫組織化學在識別組織中特定癌症標記方面的關鍵作用已在診斷、預後預測和治療選擇中變得至關重要，導致全球免疫組織化學市場的成長，特別是腫瘤學領域的需求顯著增加。同時，技術進步顯著改變了免疫組織化學技術，提高了其準確性、靈敏度和同時處理多個標記的能力。這項進步擴大了應用範圍，並促進了在各種研究和臨床領域的採用。

此外，對個人化醫療日益增長的興趣以及該領域的大量投資正在推動對準確和量身定制的診斷方法的需求。免疫組織化學提供對疾病病理學的個人化見解的能力與向個人化患者護理的範式轉移無縫結合。此外，醫療保健支出的大幅增加，尤其是診斷技術的支出，有力地支持了全球免疫組織化學市場的擴張。各個醫療領域對可靠診斷工具的需求進一步鞏固了全球免疫組織化學市場的持續成長。

該報告考察了全球免疫組織化學市場，並提供了市場概述，包括按產品、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章2017-2031年全球免疫組織化學市場展望

  • 市場規模及預測
  • 按產品
  • 按用途
  • 按最終用戶
  • 按地區
  • 按公司劃分的市佔率 (%)，2023 年

第 5 章 2017-2031 年全球免疫組織化學市場展望（按地區）

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章 市場測繪，2023 年

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要公司展望

  • Agilent Technologies, Inc.
  • Danaher Corporation
  • PHC Holdings Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Abcam plc
  • PerkinElmer Inc.
  • Takara Bio Inc.

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX10936

Global immunohistochemistry market size was valued at USD 3.01 billion in 2023, which is expected to reach USD 4.99 billion in 2031, with a CAGR of 6.51% for the forecast period between 2024 and 2031F. The growth of the global immunohistochemistry market is driven by rising cancer rates, technological progress, expanding research endeavors, the surge in personalized medicine demand, increased healthcare spending, and the necessity for precise diagnostic instruments.

The growth of the global immunohistochemistry market hinges on a multitude of pivotal factors driving its upward momentum. Initially, the surging prevalence of global cancer cases serves as a primary catalyst. Immunohistochemistry's pivotal role in identifying specific cancer markers in tissues has become indispensable in diagnosing, prognosing, and selecting treatments, thereby significantly boosting its demand in the global immunohistochemistry market, particularly within oncology. Simultaneously, the landscape of technological advancements has profoundly transformed immunohistochemistry methodologies, elevating their precision, sensitivity, and ability to handle multiple markers concurrently. The progression has widened the array of applications, fostering its adoption across diverse research and clinical fields.

Furthermore, the burgeoning interest in personalized medicine and the substantial investments in this realm have fueled the need for accurate, tailored diagnostic approaches. Immunohistochemistry's capacity to provide personalized insights into disease pathology seamlessly aligns with the paradigm shift toward individualized patient care. Moreover, the substantial rise in healthcare expenditure, notably in diagnostic technologies, has provided robust support for expanding the global immunohistochemistry market. The imperative demand for dependable diagnostic tools across varied medical domains further solidifies the sustained growth of global immunohistochemistry market.

Rising Cancer Rates

The expansion of the global immunohistochemistry market stems from the worldwide increase in cancer rates. With the surge in cancer cases, there's an amplified necessity for precise diagnostic tools. Immunohistochemistry stands out for its capability to pinpoint proteins and biomarkers within tissues, which is critical in diagnosing, prognosing, and selecting treatments for cancer. Technology allows for the accurate identification and characterization of cancerous cells, assisting medical professionals in comprehending tumor behavior and devising customized treatment plans. The growing demand for efficient, personalized cancer therapies has led to a wider adoption of immunohistochemistry techniques. Its capacity to offer intricate insights into various tumor types and molecular compositions has solidified its indispensable status in oncology. Consequently, the ongoing escalation of cancer incidence is a pivotal driver fueling the continual growth and expansion of the global immunohistochemistry market.

Technological Advancements

Technological progress is the primary driver behind expanding the global immunohistochemistry market. Advancements in this arena have transformed methodologies, boosting precision, sensitivity, and the ability to handle multiple markers simultaneously. These developments expand the range of applications for immunohistochemistry, fostering its use across various research and clinical fields. Evolution allows for the precise detection and characterization of specific proteins and biomarkers in tissues, crucial for precise diagnosis, prognosis, and treatment decisions. Consequently, the ongoing innovation and enhancement of technology significantly contribute to the market's growth by enhancing effectiveness, dependability, and the breadth of insights provided by immunohistochemistry methods.

Launched in September 2023, SignalStar Multiplex IHC technology is a game-changing new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays. Cell Signalling Technology (CST) is a life science discovery technology company and a leading provider of antibodies, kits, and services. Using flexible, thoroughly validated antibody panels, the SignalStar method concurrently identifies up to eight targets in formalin-fixed, paraffin-embedded (FFPE) tissues, enabling the investigation of cellular presence, location, function, and biomarker coexpression patterns.

IHC for Cancer Treatment

The increasing need for immunohistochemistry in treating cancer is a crucial driver for the global immunohistochemistry market. Its essential function involves accurately diagnosing cancer, predicting outcomes, and guiding treatment choices. Immunohistochemistry assists in customizing treatment plans by identifying precise proteins and biomarkers in tissues. As personalized medicine gains traction, the technology's role in providing intricate details about tumor features becomes more vital. The growing dependence on immunohistochemistry in cancer management fuels its acceptance, propelling market expansion as healthcare systems globally emphasize precise and individualized methods to address the complexities associated with cancer.

Leica Biosystems announced on April 20, 2023, that the BOND MMR Antibody Panel has received US Food and Drug Administration (FDA) 510(k) clearance. The clearance gives customers an excellent option for IHC Mismatch Repair (MMR) when screening patients with colorectal cancer for the presence of probable Lynch syndrome. The Leica Biosystems BOND MMR panel on the BOND-III allows pathologists to analyze the state of mismatch repair proteins quickly and accurately in about 2.5 hours. Clinicians can feel more confident in their MMR results with the panel.

Dominance of Antibody Products

The dominance of antibody products in the global immunohistochemistry market is a crucial catalyst. Antibodies are pivotal in these assays, selectively binding to target proteins and facilitating their detection in tissue samples. The market's expansion is driven by the growing utilization of antibodies in research and diagnostic contexts. Their precision and sensitivity render them essential in pinpointing disease markers, crucial for precise diagnoses and treatment planning. With the increasing demand for accurate detection techniques, the indispensable nature of antibody products consistently propels the growth of the global immunohistochemistry market.

The global antibody manufacturing company GeneTex stated in June 2023 that it will use its platform for producing recombinant monoclonal antibodies to provide best-in-class biomedical research reagents. The specificity of these novel antibodies is established through rigorous internal validation testing based on knockdown/knockout approaches supplemented by additional strategies. Using the procedure, GeneTex created and validated a new recombinant rabbit monoclonal antibody for immunohistochemistry (IHC) called programmed death-ligand 1 (PD-L1).

Future Market Scenario

The prospects for the global immunohistochemistry market are positive and positioned for substantial expansion. Several factors underpin the positive forecast. Ongoing technological advancements consistently improve the precision, sensitivity, and multiplexing capabilities of immunohistochemistry methods, broadening their use in various research and clinical realms. Also, the increasing prevalence of global diseases, particularly cancer, intensifies the need for accurate diagnostic tools, emphasizing the vital role of immunohistochemistry in identifying specific disease markers in tissues.

Furthermore, the growing emphasis on personalized medicine encourages the adoption of immunohistochemistry for its ability to offer intricate insights into personalized disease attributes, aligning well with the trend toward individualized patient care. Continued governmental support, augmented investments in healthcare infrastructure, and the indispensable nature of antibody products in the sector collectively signal a promising future for the global immunohistochemistry market, ensuring sustained growth and innovative strides in diagnostics and tailored healthcare solutions.

Key Players Landscape and Outlook

Major participants in the global immunohistochemistry market are proactively seeking strategic alliances to propel progress and creativity. These partnerships encompass teaming up with research organizations, healthcare entities, and tech companies to augment research initiatives and broaden market influence. Collaborative ventures and alliances provide access to diverse expertise, technologies, and resources, nurturing the advancement of sophisticated immunohistochemistry solutions. Such partnerships further enable market entry, empowering companies to harness collective capabilities, innovate new uses, and introduce enhanced diagnostic instruments. The concerted effort amplifies their competitive advantage and fortifies the market's growth and evolution by delivering improved offerings. Agilent Technologies, Inc. and Akoya Biosciences, Inc. announced a collaboration in January 2023 to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to market workflow solutions for multiplex assays in the clinical research market. One end-to-end commercial workflow includes reagents, staining, imaging, and analysis created by integrating Agilent's Dako Omnis (autostaining instrument) and Akoya's PhenoImager HT (imaging platform) for multiplex chromogenic immunohistochemistry (mIHC) and immunofluorescent (mIF) assays.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Immunohistochemistry Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. Reagents
      • 4.2.1.1. Fixation Reagents
      • 4.2.1.2. Proteolytic Enzymes
      • 4.2.1.3. Organic Solvents
      • 4.2.1.4. Chromogenic Substrates
      • 4.2.1.5. Histological Stains
      • 4.2.1.6. Diluents
      • 4.2.1.7. Blocking Sera and Reagents
      • 4.2.1.8. Others
    • 4.2.2. Equipment
      • 4.2.2.1. Tissue Processing Systems
      • 4.2.2.2. Slide Scanners
      • 4.2.2.3. Slide-staining systems
      • 4.2.2.4. Others
    • 4.2.3. Antibodies
      • 4.2.3.1. Primary antibodies
      • 4.2.3.2. Secondary antibodies
    • 4.2.4. Kits
      • 4.2.4.1. IHC Kits for Human Tissue
      • 4.2.4.2. IHC Kits for Animal Tissue
  • 4.3. By Applications
    • 4.3.1. Diagnostic
      • 4.3.1.1. Infectious Diseases
      • 4.3.1.2. Neurological Diseases
      • 4.3.1.3. Autoimmune Diseases
      • 4.3.1.4. Cancer
      • 4.3.1.5. Nephrological Diseases
      • 4.3.1.6. Others
    • 4.3.2. Research
      • 4.3.2.1. Drug development and Testing
      • 4.3.2.2. Others
    • 4.3.3. Forensic
  • 4.4. By End-users
    • 4.4.1. Hospitals and Diagnostic Laboratories
    • 4.4.2. Academic and Research Institutes
    • 4.4.3. Others
  • 4.5. By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. South America
    • 5.4.4. Asia-Pacific
    • 5.4.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Immunohistochemistry Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product
      • 5.1.2.1. Reagents
      • 5.1.2.1.1. Fixation Reagents
      • 5.1.2.1.2. Proteolytic Enzymes
      • 5.1.2.1.3. Organic Solvents
      • 5.1.2.1.4. Chromogenic Substrates
      • 5.1.2.1.5. Histological Stains
      • 5.1.2.1.6. Diluents
      • 5.1.2.1.7. Blocking Sera and Reagents
      • 5.1.2.1.8. Others
      • 5.1.2.2. Equipment
      • 5.1.2.2.1. Tissue Processing Systems
      • 5.1.2.2.2. Slide Scanners
      • 5.1.2.2.3. Slide-staining systems
      • 5.1.2.2.4. Others
      • 5.1.2.3. Antibodies
      • 5.1.2.3.1. Primary antibodies
      • 5.1.2.3.2. Secondary antibodies
      • 5.1.2.4. Kits
      • 5.1.2.4.1. IHC Kits for Human Tissue
      • 5.1.2.4.2. IHC Kits for Animal Tissue
    • 5.1.3. By Applications
      • 5.1.3.1. Diagnostic
      • 5.1.3.1.1. Infectious Diseases
      • 5.1.3.1.2. Neurological Diseases
      • 5.1.3.1.3. Autoimmune Diseases
      • 5.1.3.1.4. Cancer
      • 5.1.3.1.5. Nephrological Diseases
      • 5.1.3.1.6. Others
      • 5.1.3.2. Research
      • 5.1.3.2.1. Drug development and Testing
      • 5.1.3.2.2. Others
      • 5.1.3.3. Forensic
    • 5.1.4. By End-users
      • 5.1.4.1. Hospitals and Diagnostic Laboratories
      • 5.1.4.2. Academic and Research Institutes
      • 5.1.4.3. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. Value
      • 5.1.5.1.2. Volume
      • 5.1.5.2. By Product
      • 5.1.5.2.1. Reagents
      • 5.1.5.2.1.1. Fixation Reagents
      • 5.1.5.2.1.2. Proteolytic Enzymes
      • 5.1.5.2.1.3. Organic Solvents
      • 5.1.5.2.1.4. Chromogenic Substrates
      • 5.1.5.2.1.5. Histological Stains
      • 5.1.5.2.1.6. Diluents
      • 5.1.5.2.1.7. Blocking Sera and Reagents
      • 5.1.5.2.1.8. Others
      • 5.1.5.2.2. Equipment
      • 5.1.5.2.2.1. Tissue Processing Systems
      • 5.1.5.2.2.2. Slide Scanners
      • 5.1.5.2.2.3. Slide-staining systems
      • 5.1.5.2.2.4. Others
      • 5.1.5.2.3. Antibodies
      • 5.1.5.2.3.1. Primary antibodies
      • 5.1.5.2.3.2. Secondary antibodies
      • 5.1.5.2.4. Kits
      • 5.1.5.2.4.1. IHC Kits for Human Tissue
      • 5.1.5.2.4.2. IHC Kits for Animal Tissue
      • 5.1.5.3. By Applications
      • 5.1.5.3.1. Diagnostic
      • 5.1.5.3.1.1. Infectious Diseases
      • 5.1.5.3.1.2. Neurological Diseases
      • 5.1.5.3.1.3. Autoimmune Diseases
      • 5.1.5.3.1.4. Cancer
      • 5.1.5.3.1.5. Nephrological Diseases
      • 5.1.5.3.1.6. Others
      • 5.1.5.3.2. Research
      • 5.1.5.3.2.1. Drug development and Testing
      • 5.1.5.3.2.2. Others
      • 5.1.5.3.3. Forensic
      • 5.1.5.4. By End-users
      • 5.1.5.4.1. Hospitals and Diagnostic Laboratories
      • 5.1.5.4.2. Academic and Research Institutes
      • 5.1.5.4.3. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Applications
  • 6.3. By End-users
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Agilent Technologies, Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Danaher Corporation
  • 13.3. PHC Holdings Corporation
  • 13.4. Bio-Rad Laboratories, Inc.
  • 13.5. Bio-Techne Corporation
  • 13.6. Merck KGaA
  • 13.7. Thermo Fisher Scientific, Inc.
  • 13.8. Abcam plc
  • 13.9. PerkinElmer Inc.
  • 13.10. Takara Bio Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 3. Global Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 5. Global Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 6. Global Immunohistochemistry Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 9. North America Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 11. North America Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 12. North America Immunohistochemistry Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 15. United States Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 16. United States Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 17. United States Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 18. Canada Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 20. Canada Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 21. Canada Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 22. Canada Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 23. Mexico Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 25. Mexico Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 26. Mexico Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 27. Mexico Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 28. Europe Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 30. Europe Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 31. Europe Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 32. Europe Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 33. Europe Immunohistochemistry Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 36. Germany Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 37. Germany Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 38. Germany Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 39. France Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 41. France Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 42. France Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 43. France Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 44. Italy Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 46. Italy Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 47. Italy Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 48. Italy Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 49. United Kingdom Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 51. United Kingdom Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 52. United Kingdom Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 53. United Kingdom Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 54. Russia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 56. Russia Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 57. Russia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 58. Russia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 59. Netherlands Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 61. Netherlands Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 62. Netherlands Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 63. Netherlands Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 64. Spain Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 66. Spain Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 67. Spain Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 68. Spain Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 69. Turkey Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 71. Turkey Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 72. Turkey Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 73. Turkey Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 74. Poland Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 76. Poland Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 77. Poland Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 78. Poland Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 79. South America Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 81. South America Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 82. South America Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 83. South America Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 84. South America Immunohistochemistry Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 87. Brazil Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 88. Brazil Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 89. Brazil Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 90. Argentina Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 92. Argentina Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 93. Argentina Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 94. Argentina Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 95. Asia-Pacific Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 97. Asia-Pacific Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 98. Asia-Pacific Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 99. Asia-Pacific Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 100. Asia-Pacific Immunohistochemistry Market Share (%), By Country, 2017-2031F
  • Figure 101. India Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 103. India Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 104. India Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 105. India Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 106. China Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 108. China Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 109. China Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 110. China Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 111. Japan Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 113. Japan Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 114. Japan Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 115. Japan Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 116. Australia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 118. Australia Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 119. Australia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 120. Australia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 121. Vietnam Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 123. Vietnam Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 124. Vietnam Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 125. Vietnam Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 126. South Korea Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 128. South Korea Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 129. South Korea Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 130. South Korea Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 131. Indonesia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 133. Indonesia Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 134. Indonesia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 135. Indonesia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 136. Philippines Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 138. Philippines Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 139. Philippines Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 140. Philippines Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 141. Middle East & Africa Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 143. Middle East & Africa Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 144. Middle East & Africa Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 145. Middle East & Africa Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 146. Middle East & Africa Immunohistochemistry Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 149. Saudi Arabia Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 150. Saudi Arabia Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 151. Saudi Arabia Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 152. UAE Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 154. UAE Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 155. UAE Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 156. UAE Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 157. South Africa Immunohistochemistry Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Immunohistochemistry Market, By Volume, in Thousands, 2017-2031F
  • Figure 159. South Africa Immunohistochemistry Market Share (%), By Product, 2017-2031F
  • Figure 160. South Africa Immunohistochemistry Market Share (%), By Applications, 2017-2031F
  • Figure 161. South Africa Immunohistochemistry Market Share (%), By End-users, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023